MF: C6H12O6
MW: 180.16
CAS: 643-12-9
D-chiro-inositol (DCI) is one of the nine isomers of inositol with optical activity. In recent years, studies have found that D-chiral inositol (DCI) not only has inositol to promote liver lipid metabolism, but also has sensitization, hypoglycemia, improve ovulation in patients with polycystic ovary syndrome (PCOS), regulate hormone balance, improve menstrual disorders, and anti-oxidation, anti-aging, anti-inflammation special physiological functions. Therefore, D-chiral inositol can be used as medicine, health products and dietary supplements, and has broad development prospects. D-chiral inositol is a member of the inositol family, although "inositol". Includes several biologically active isomers, including L-chiral inositol. MYO (myinositol) is converted to DCI (D-chiral inositol) by an idependent NAD/NADH differential to isomerase. It is widely recognized as an important co-messenger in signaling. DCI (D-chiral inositol) accelerates dephosphorylation of glycogen synthetase and pyruvate dehydrogenase, promoting both non-oxidizing and oxidizing glucose treatment by rate-limiting enzymes. DCI (D-chiral inositol) can reduce resistance due to defects in differential isomerization of muscle inositol to chiral inositol, at least partially restoring sensitivity and glucose processing. D-chiral inositol is a nutrient present in the body itself, which allows the body cells to better recognize it and do not reject it. In 1994, the U.S. Dietary Supplement Health and Education Act certified D-chiral inositol as a dietary supplement